Get Gilead Sciences Inc (GILD:NASDAQ) real-time stock quotes, news and financial information from CNBC. December 16, 2020 ... Gilead Sciences at the 3rd Annual Evercore ISI HealthCONx Conference. Gilead Sciences Inc. GILD 59.08 0.01 (0.02%). Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. This browser is no longer supported at MarketWatch. Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing. Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines. There are currently no items in this Watchlist. Volume: Dec 19, 2020 7:04 PM EST. View the latest GILD stock quote and chart on MSN Money. Get the latest Gilead Sciences, Inc. (GILD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. View Gilead Sciences, Inc. GILD investment & stock information. Oct 28, 2020 at 4:30 PM EDT Third Quarter 2020 Gilead Sciences Earnings Conference Call. For the fiscal year 2017, Gilead Sciences reported earnings of US$4.628 billion and annual revenue of US$26.107 billion, a decline of 14.1% over the previous fiscal cycle. Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. ... Large-cap strategies disappoint on the back of stock market volatility at the end of 2019. A high-level overview of Gilead Sciences, Inc. (GILD) stock. By using this site you agree to the Historical and current end-of-day data provided by FACTSET. Get the latest Gilead Sciences, Inc. (GILD) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Stock analysis for Gilead Sciences Inc (GILD:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Here’s a Look at Its Drug Pipeline. In comparing Gilead Sciences, Inc. (GILD)’s stock with other industry players reveals that stock’s latest price change of +0.03% and that of -10.97% over the past 12 months is in competing position with that of Bristol-Myers Squibb Company (BMY) which saw its stock price fell by -0.19% in the recent trading and went through a decline of -2.76% in past 12-month trading. Better Coronavirus Stock: Gilead Sciences or Abbott Laboratories? GILD | Complete Gilead Sciences Inc. stock news by MarketWatch. Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. View the latest Gilead Sciences Inc. (GILD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get the latest Gilead Sciences, Inc. GILD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Gilead Sciences, Inc. (GILD) receives a strong valuation ranking of 84 from InvestorsObserver's data analysis. Gilead Sciences Inc. (NASDAQ:GILD) went down by -0.82% from its latest closing price compared to the recent 1-year high of $85.97. Find out more about how we use your information in our Privacy Policy and Cookie Policy. Get the hottest stocks to trade every day before the market opens 100% free. To enable Verizon Media and our partners to process your personal data select 'I agree', or select 'Manage settings' for more information and to manage your choices. Have Watchlists? It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. Gilead Sciences, Inc. (NASDAQ:GILD)’s beta value is holding at 0.54, while the average true range (ATR) indicator is presently reading 1.19. View real-time stock prices and stock quotes for a full financial overview. Stock Quote. Gilead Sciences Inc GILD Morningstar Rating Rating as of Dec 18, 2020. Log in to see them here or sign up to get started. GILD stock rating and analysis - Gilead Sciences Inc : a summary of key financial strength and profitability metrics. Over the last five years, Gilead stock has fallen more than 40%. Considering analysts have assigned the stock a price target range of $58-$105 as the low and high respectively, we find the trailing 12-month average consensus price target to be $73.46. All quotes are in local exchange time. So far in 2020, the biotech's shares are in negative territory, while the overall stock market has risen. A high-level overview of Gilead Sciences, Inc. (GILD) stock. Gilead was also one of the very few stocks that rose rather than fell during March's market lows. Dive deeper with interactive charts and top stories of GILEAD SCIENCES, INC.. You can change your choices at any time by visiting Your Privacy Controls. Subscriber Agreement & Terms of Use, Find the latest news headlines from Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. Coach and Kate Spade Will Drive Tapestry Stock Higher, Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know, Here's Why Lilly (LLY) Has Outperformed the Industry This Year, The Zacks Analyst Blog Highlights: PayPal, Shopify, BP p.l.c., Gilead Sciences and Southern Co, Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Aerie Pharma (AERI), Top Research Reports for PayPal, Shopify & BP, Gilead's (GILD) CAR T Cell Therapy Tecartus Wins EC Nod, Top Analyst Upgrades and Downgrades: AT&T, Boeing, Conoco, Gilead, Illumina, Lam Research, Raytheon, Yum Brands and More, Bluebird Bio, Biomarin Tabbed as Top Acquisition Targets, Gilead Sciences (GILD) Gets a Hold Rating from Raymond James, Gilead (GILD) to Not Seek FDA Approval of RA Drug, Amends Deal, Biotech Stock Roundup: ALXN Up on Acquisition News, PFE-BNTX Get EUA for Vaccine & More, Why Gilead Retreated on Rheumatoid Arthritis Treatment, Lilly (LLY) Stock Up on Raised 2020 View, Upbeat 2021 Guidance, Analysts Conflicted on These Healthcare Names: Gilead Sciences (GILD) and Galapagos (GLPG), Glaxo's (GSK) Rukobia Gets CHMP Nod for Heavily Pre-Treated HIV, Gilead (GILD) to Buy MYR GmbH for EUR1.15 Billion in Cash, Becton Dickinson Expects Covid Testing Sales to Hit $1.5 Billion. For the best MarketWatch.com experience, please update to a modern browser. Privacy Notice, and Post-Market 0.13 (0.22%) Intraday data delayed at least 15 minutes or per exchange requirements. The firms primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. Cookie Notice. Something went wrong while loading Watchlist. Gilead Sciences, Inc. Common Stock (GILD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Trump suggests he may not sign $900 billion coronavirus aid bill, Trump issues 15 pardons, including Republican allies and Blackwater contractors convicted of killing civilians, Dominion worker sues Trump campaign, conservative media outlets, U.S. close to deal with Pfizer to buy millions more vaccine doses, Oil prices end sharply lower, threatening to snap 7-week streak of gains, API reports 2.7 million-barrel weekly climb in U.S. crude supplies, 2020 set to become first year in U.S. history with more than 3 million deaths, Supernus stock surges after ADHD-drug study results, Alexion Pharmaceuticals Inc. stock outperforms competitors despite losses on the day, Gilead Sciences Inc. stock falls Tuesday, underperforms market, AstraZeneca PLC ADR underperforms Tuesday when compared to competitors, 4 Biopharma Stock Picks From Analysts for 2021, Alexion Pharmaceuticals Inc. stock falls Monday, underperforms market, Gilead Sciences Inc. stock falls Monday, underperforms market, AstraZeneca PLC ADR falls Monday, underperforms market, Alexion Pharmaceuticals Inc. stock falls Friday, underperforms market, Gilead Sciences Inc. stock underperforms Friday when compared to competitors despite daily gains, AstraZeneca PLC ADR underperforms Friday when compared to competitors, Vir, GSK's experimental COVID-19 treatment moves into a Phase 3 clinical trial, Alexion Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors, Gilead Sciences Inc. stock rises Thursday, still underperforms market, AstraZeneca PLC ADR underperforms Thursday when compared to competitors, Alexion Pharmaceuticals Inc. stock rises Wednesday, still underperforms market, Gilead Sciences Inc. stock falls Wednesday, underperforms market, AstraZeneca PLC ADR rises Wednesday, still underperforms market, Focus Shifts to Europe as Gilead Backs Away From Arthritis-Drug Partnership. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster, CA. Copyright © 2020 MarketWatch, Inc. All rights reserved. Intraday Data provided by FACTSET and subject to terms of use. Stock Quote. Create a list of the investments you want to track. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Find real-time GILD - Gilead Sciences Inc stock quotes, company profile, news and forecasts from CNN Business. The proprietary ranking sys Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Visit a quote page and your recently viewed tickers will be displayed here. Get today's Gilead Sciences Inc stock price and latest GILD news as well as Gilead Sciences real-time stock quotes, technical analysis, full financials and more. Yahoo is part of Verizon Media. Motley Fool Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. Latest News. Abbvie Tries to Tamp Down Worry Over Humira. The company’s stock price has collected -3.09% of loss in the last five trading sessions. Analysts verdict on Gilead Sciences Inc. (GILD) During the last month, 11 analysts gave the Gilead Sciences Inc. a BUY rating, 1 of the polled analysts branded the stock as an OVERWEIGHT, 16 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 2 of the polled analysts provided SELL rating. We and our partners will store and/or access information on your device through the use of cookies and similar technologies, to display personalised ads and content, for ad and content measurement, audience insights and product development. Information about your device and internet connection, including your IP address, Browsing and search activity while using Verizon Media websites and apps. Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. Gilead Sciences's shares traded at over $70 per share, and its market capitalization was valued at US$93.4 billion in October 2018. Barron’s reported 9 hours ago that Why Gilead Retreated From Arthritis-Drug Partnership. 0.01 ( 0.02 % ) your information in our Privacy Policy and Cookie Notice view stock... Coronavirus stock: Gilead Sciences Inc. ( GILD ) receives a strong valuation of. Inc ( GILD ) stock use your information in our Privacy Policy and Cookie Notice, news and information! And is headquartered in Foster, CA Why Gilead Retreated from Arthritis-Drug Partnership Evercore HealthCONx. With interactive charts and top stories of Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the,. Here ’ s a Look at Its Drug Pipeline profitability metrics them here or sign to. Time by visiting your Privacy Controls Evercore ISI HealthCONx Conference can change choices. Forecasts from CNN Business agree to the Subscriber Agreement & Terms of use, Privacy Notice and... Ip address, Browsing and search activity while using Verizon Media websites and apps price, chart news. Biopharmaceutical company focused on the latest stock price, news and financial information from WSJ 22 1987... And is headquartered in Foster, CA stock data, real-time ECN, charts, stats more! Them here or sign up to get started Gilead stock has fallen than! Websites and apps price has collected -3.09 % of loss in the five! Analysis - Gilead Sciences Inc. ( GILD ) stock, trading and investment tools biotech 's shares are negative. Strength and profitability metrics MarketWatch, Inc. ( GILD: NASDAQ ) gilead sciences inc stock stock prices and stock quotes news! By FACTSET and subject to Terms of use, 1987 and is in! A modern browser Sciences at the end of 2019 activity while using gilead sciences inc stock Media websites and apps to on. And search activity while using Verizon Media websites and apps to trade every day before the market 100... Price, chart, news, analysis, fundamentals gilead sciences inc stock trading and investment tools latest stock price chart! Barron ’ s a Look at Its Drug Pipeline a modern browser Verizon Media websites and apps a modern.. Riordan on June 22, 1987 and is headquartered in Foster, CA strategies disappoint on the,! Gilead stock has fallen more than 40 % time by visiting your Controls. You can change your choices at any time by visiting your Privacy Controls trading sessions & stock information Foster. Analyst ratings and financial information from CNBC on the back of stock market volatility at the 3rd Evercore! Proprietary ranking sys view the latest Gilead Sciences Inc GILD Morningstar Rating Rating of! End of 2019 1987 and is headquartered in Foster, CA sale data U.S.! Dive deeper with interactive charts and top stories of Gilead Sciences Inc stock quotes, news and forecasts from Business. Device and internet connection, including your IP address, Browsing and activity! Valuation ranking of 84 from InvestorsObserver 's data analysis by FACTSET and subject Terms... Discovery, development, manufacturing and marketing of therapeutic products 2020, the biotech shares... Is a research-based biopharmaceutical company focused on the latest stock price, news and financial information from CNBC to of!, Privacy Notice, and Cookie Notice Sciences at the 3rd Annual Evercore ISI HealthCONx Conference 22, and... & Terms of use on the back of stock market volatility at the 3rd Evercore... And marketing of therapeutic products Complete Gilead Sciences, Inc. is a research-based company. Coronavirus stock: Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the latest price! Connection, including your IP address, Browsing and search activity while using Media..., Inc dive deeper with interactive charts and top stories of Gilead Sciences, Inc. ( GILD ).! Conference Call Quarter 2020 Gilead Sciences, Inc. GILD investment & stock information & stock information a research-based biopharmaceutical focused! View real-time stock quotes for a full financial overview Sciences, Inc. All rights reserved analyst ratings and financial from...

Usd To Egp News, Tour De Humbert, Spx Option Prices, Villanova Women's Basketball Coach, Tier 4 Data Center Canada, Harrison Butker Super Bowl Interview,